HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$34.74
Day range
$33.20 - $35.34
Year range
$21.73 - $71.71
Market cap
2.09B USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 10.00M | 2,177.90% |
Operating expense | 41.19M | 21.47% |
Net income | -24.31M | 13.35% |
Net profit margin | -243.13 | 96.20% |
Earnings per share | -0.39 | 23.53% |
EBITDA | -34.75M | 1.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 988.99M | 50.30% |
Total assets | 1.02B | 47.44% |
Total liabilities | 48.21M | 23.89% |
Total equity | 976.56M | — |
Shares outstanding | 60.15M | — |
Price to book | 2.14 | — |
Return on assets | -8.57% | — |
Return on capital | -8.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -24.31M | 13.35% |
Cash from operations | -12.86M | -476.24% |
Cash from investing | 8.31M | -34.46% |
Cash from financing | 493.00K | -70.10% |
Net change in cash | -4.06M | -133.55% |
Free cash flow | -6.09M | -195.15% |
About
Founded
2017
Website
Employees
109
